BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Delcath Systems, Inc. (DCTH)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Delcath Systems, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
4:21 pm
Sale		 2024-09-30 13G Delcath Systems, Inc.
DCTH		 BIOTECHNOLOGY VALUE FUND L P 1,041,667
3.600%		 -1,296,759decrease
(-55.45%)		 Filing
2024-02-14
10:08 am
Purchase		 2023-12-31 13G Delcath Systems, Inc.
DCTH		 BIOTECHNOLOGY VALUE FUND L P 2,338,426
9.990%		 776,912increase
(+49.75%)		 Filing
2023-06-22
4:47 pm
Purchase		 2023-06-12 13G Delcath Systems, Inc.
DCTH		 BIOTECHNOLOGY VALUE FUND L P 1,561,514
9.990%		 1,561,514increase
(New Position)		 Filing